A twice-yearly injectable HIV prevention drug has arrived in South Africa. The rollout of the drug, lenacapavir, is underway in the country that needs it the most, about a-year-and-a-half after US aid cuts hit some of its HIV programmes. South African President Cyril Ramaphosa told crowds gathered for its launch at Lilian Ngoyi stadium in Secunda, Mpumalanga province, that the introduction of lenacapavir was a turning point in South Africa’s fight against HIV.